SHPH (Shuttle Pharmaceuticals Holdings) Short Ratio


SHPH Shuttle Pharmaceuticals Holdings Inc SHPH
24 GF Score
Price $3.28
! 1 Warning Sign
View Full Analysis

What is Shuttle Pharmaceuticals Holdings Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHPH
24GF Score
Shuttle Pharmaceuticals Holdings Inc SHPH
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shuttle Pharmaceuticals Holdings Business Description

Address 401 Professional Drive, Suite 260, Gaithersburg, MD, USA, 20879
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
24GF Score

Get the complete analysis for SHPH

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.28
Price